FindMyRecallSubscribe
Class II: temporary or reversible health riskOngoing

Baxter Healthcare Regadenoson Injection Recall

Regadenoson Injection, 0

Baxter Healthcare Corporation · Deerfield, IL

Risk level
Class II
Reported by FDA
Nov 13, 2024
Recall ID
D-0039-2025
Check your lot numberHow we source this data

Summary

Baxter Healthcare recalled Regadenoson Injection starting Oct 30, 2024. The FDA classified it as Class II (temporary or reversible health risk) and published enforcement report D-0039-2025 on Nov 13, 2024. Reason: Labeling: Missing Label. Status: Ongoing.

Why it was recalled

Labeling: Missing Label

Product description

Regadenoson Injection, 0.4 mg/5 mL (0.08 mg/mL), 5mL Single-Dose Pre-filled Syringe, Rx only, Manufactured by: Baxter Pharmaceutical Solutions, LLC, Bloomington, IN 47403; Manufactured for: Baxter Healthcare Corporation, Deerfield, IL 60015. NDC: 36000-364-01

Lot numbers, UPCs & expiration codes

Lot #: 945169, Exp. Date 9/25/2025; 945170, Exp. Date 10/24/2025

Where it was sold

Nationwide within the USA

What to do if you have this product

  • Compare the lot number and expiration date on your package with the codes above.
  • Don't stop taking a prescription medicine on your own. Call your pharmacist or doctor; they can confirm whether your supply is affected and arrange a replacement.
  • If you have symptoms you think are related, contact your doctor. In an emergency call 911.
  • Report side effects to FDA MedWatch at 1-800-FDA-1088.

Recall details

Recall number
D-0039-2025
Classification
Class II
Status
Ongoing
Recall initiated
Oct 30, 2024
FDA report date
Nov 13, 2024
Quantity
60,594 units
Recall type
Voluntary: Firm initiated
Recalling firm
Baxter Healthcare Corporation

Original FDA data

Every field from FDA enforcement report D-0039-2025, exactly as published.

Show all FDA fields
City
Deerfield
State
IL
Status
Ongoing
Country
United States
Event ID
95664
Address
1 Baxter Pkwy
Code information
Lot #: 945169, Exp. Date 9/25/2025; 945170, Exp. Date 10/24/2025
Postal code
60015-4625
Report date
Nov 13, 2024
Product type
Drugs
Recall number
D-0039-2025
Classification
Class II
Recalling firm
Baxter Healthcare Corporation
Product quantity
60,594 units
Reason for recall
Labeling: Missing Label
Voluntary / mandated
Voluntary: Firm initiated
Product description
Regadenoson Injection, 0.4 mg/5 mL (0.08 mg/mL), 5mL Single-Dose Pre-filled Syringe, Rx only, Manufactured by: Baxter Pharmaceutical Solutions, LLC, Bloomington, IN 47403; Manufactured for: Baxter Healthcare Corporation, Deerfield, IL 60015. NDC: 36000-364-01
Distribution pattern
Nationwide within the USA
Recall initiation date
Oct 30, 2024
Initial firm notification
Letter
Center classification date
Nov 6, 2024

How we source this data

Source: U.S. Food and Drug Administration enforcement report D-0039-2025, published Nov 13, 2024. View the source record (openFDA) · FDA enforcement reports

Last checked against FDA data: . Content last changed: .

FindMyRecall is an independent service and is not affiliated with or endorsed by the FDA. This page simplifies the official record; the FDA or manufacturer notice is authoritative, so follow its instructions. Medication information here is not individualized medical advice.

How we source and update recall data · Report incorrect information

Other recent drug recalls